Appendix 편집하기

=약어집=
{| class="wikitable"
!Abbreviation 
!a key to Abbreviations
|-
|ABR
|Absolute bed rest
|-
|AGP
|Antegrade pyelography
|-
|A-line
|Arterial line
|-
|Anti.
|Antibiotics
|-
|ARF
|Acute renal failure
|-
|BM
|Bone marrow
|-
|BR
|Bed rest
|-
|BST
|Blood sugar test
|-
|BT
|Bleeding time
|-
|BWt
|Body weight 
|-
|Bx
|Biopsy
|-
|C-line
|Central line
|-
|CRF
|Chronic renal failure
|-
|CrCl 
|Creatinine clearance
|-
|CVP
|Central venous pressure
|-
|DIC
|Disseminated intravascular coagulation
|-
|D-J
|Double-J catheter
|-
|E'
|Electrolyte
|-
|FBS
|Fasting blood glucose
|-
|FFP
|Fresh frozen plasma
|-
|F/U
|Follow up
|-
|G.O
|Gas out
|-
|Hb 
|Hemoglobin 
|-
|Hct
|Hematocrit
|-
|HD
|Hemodialysis
|-
|H/S
|Hartman solution
|-
|HTN
|Hypertension 
|-
|I/O
|Input/Output
|-
|IV
|Intravenous
|-
|LD
|Liquid diet
|-
|LFT
|Liver function test
|-
|L-tube
|Levin tube
|-
|NRD
|Normal regular diet
|-
|N/S
|Normal saline
|-
|OP
|Operation
|-
|OSM
|Osmolarity
|-
|P/C
|Platelet concentrate
|-
|PCA
|Patient-controlled analgesia
|-
|PCN
|Percutaneous nephrostomy
|-
|PFT
|Pulmonary function test
|-
|PO
|By mouth, orally 
|-
|POD
|Post-operative day
|-
|PSA 
|Prostate specific antigen
|-
|PT
|Prothrombin time
|-
|qd
|Once daily
|-
|RGP
|Retrograde pyelography
|-
|SD
|Soft diet
|-
|SOW
|Seeps of water
|-
|TD
|Tolerable diet
|-
|TPN
|Total parenteral nutrition
|-
|TURB 
|Transurethral resection of bladder
|-
|TURP
|Transurethral resection of prostate
|-
|U.O
|Urine output
|-
|USG
|Ultrasonography
|-
|V/S
|Vital sign
|-
|W/B
|Whole blood
|-
|W/U
|Work up 
|}

=비뇨기계 종양의 병기=

== Kidney cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

{| class="wikitable"
!T category
! colspan="3" |T criteria
|-
|TX
| colspan="3" |Primary tumor cannot be assessed
|-
|T0
| colspan="3" |No evidence of primary tumor
|-
|T1
| colspan="3" |Tumor ≤7 cm in greatest dimension, limited to the kidney
|-
|T1a
| colspan="3" |Tumor ≤4 cm in greatest dimension, limited to the kidney
|-
|T1b
| colspan="3" |Tumor >4 cm but ≤7 cm in greatest dimension, limited to the kidney
|-
|T2
| colspan="3" |Tumor >7 cm in greatest dimension, limited to the kidney
|-
|T2a
| colspan="3" |Tumor >7 cm but ≤10 cm in greatest dimension, limited to the kidney
|-
|T2b
| colspan="3" |Tumor >10 cm, limited to the kidney
|-
|T3
| colspan="3" |Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia
|-
|T3a
| colspan="3" |Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond Gerota's fascia
|-
|T3b
| colspan="3" |Tumor extends into the vena cava below the diaphragm 
|-
|T3c
| colspan="3" |Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava
|-
|T4
| colspan="3" |Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland)
|-
| colspan="4" |Regional lymph nodes (N)
|-
|N category
| colspan="3" |N criteria
|-
|NX
| colspan="3" |Regional lymph nodes cannot be assessed
|-
|N0
| colspan="3" |No regional lymph node metastasis
|-
|N1
| colspan="3" |Metastasis in regional lymph node(s)
|-
| colspan="4" |Distant metastasis (M)
|-
|M category
| colspan="3" |M criteria
|-
|M0
| colspan="3" |No distant metastasis
|-
|M1
| colspan="3" |Distant metastasis
|-
| colspan="4" |Prognostic stage groups
|-
|When T is... 
|And N is...
|And M is... 
|Then the stage group is... 
|-
|T1
|N0
|M0
|I
|-
|T1
|N1
|M0
|III
|-
|T2
|N0
|M0
|II
|-
|T2
|N1
|M0
|III
|-
|T3
|NX, N0
|M0
|III
|-
|T3
|N1
|M0
|III
|-
|T4
|Any N
|M0
|IV
|-
|Any T
|Any N
|M1
|IV
|}
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

== Tumors of the renal pelvis and ureter TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control. 

== Bladder cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control. 

== Prostate cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control. 

== Testicular cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; LDH: lactate dehydrogenase; hCG: human chorionic gonadotropin; AFP: alphafetoprotein. 

== Urethral cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control. 

== Cancer of the penis TNM staging AJCC UICC 2017 ==
Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; ENE: extranodal extension.

=실험실검사 참조수치=

== TABLE 1. Hematology and Coagulation ==

== TABLE 2. Clinical Chemistry and Immunology ==

== TABLE 3. Classification of LDL, Total, and HDL Cholesterol ==

== TABLE 4. Urine Analysis and Renal Function Tests ==

== TABLE 5. Body Fluids and Other Mass Data ==

=비뇨기과 상병코드=